Food allergen immunotherapy

Current status and prospects for the future

Research output: Contribution to journalArticle

Abstract

Food allergy is a common condition for which the only currently approved treatments are avoidance of the allergenic food and administration of emergency medications on accidental exposure. Over the past 10 years, significant advances have been made in the field of food immunotherapy, including oral immunotherapy, sublingual immunotherapy, and, more recently, epicutaneous immunotherapy. Each of these approaches are intended to induce some level of desensitization with chronic or repeated exposure to the allergenic food protein, although the risks and potential benefits of each treatment differ significantly. Although new data are emerging at a rapid pace and progress has been substantial, a number of important issues need to be addressed before introduction of these therapies into clinical practice. Furthermore, it is entirely possible that advances in this field will render these current approaches obsolete over the next 20 to 30 years as new and better therapies are developed.

Original languageEnglish (US)
Pages (from-to)973-982
Number of pages10
JournalThe Journal of Allergy and Clinical Immunology
Volume137
Issue number4
DOIs
StatePublished - Apr 1 2016

Fingerprint

Immunologic Desensitization
Immunotherapy
Food
Sublingual Immunotherapy
Food Hypersensitivity
Therapeutics
Emergencies
Proteins

Keywords

  • egg allergy
  • epicutaneous immunotherapy
  • Food allergy
  • immunotherapy
  • milk allergy
  • omalizumab
  • oral immunotherapy
  • peanut allergy
  • sublingual immunotherapy

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Food allergen immunotherapy : Current status and prospects for the future. / Wood, Robert A.

In: The Journal of Allergy and Clinical Immunology, Vol. 137, No. 4, 01.04.2016, p. 973-982.

Research output: Contribution to journalArticle

@article{6a1bd48abb42419790671fc7a640c5de,
title = "Food allergen immunotherapy: Current status and prospects for the future",
abstract = "Food allergy is a common condition for which the only currently approved treatments are avoidance of the allergenic food and administration of emergency medications on accidental exposure. Over the past 10 years, significant advances have been made in the field of food immunotherapy, including oral immunotherapy, sublingual immunotherapy, and, more recently, epicutaneous immunotherapy. Each of these approaches are intended to induce some level of desensitization with chronic or repeated exposure to the allergenic food protein, although the risks and potential benefits of each treatment differ significantly. Although new data are emerging at a rapid pace and progress has been substantial, a number of important issues need to be addressed before introduction of these therapies into clinical practice. Furthermore, it is entirely possible that advances in this field will render these current approaches obsolete over the next 20 to 30 years as new and better therapies are developed.",
keywords = "egg allergy, epicutaneous immunotherapy, Food allergy, immunotherapy, milk allergy, omalizumab, oral immunotherapy, peanut allergy, sublingual immunotherapy",
author = "Wood, {Robert A}",
year = "2016",
month = "4",
day = "1",
doi = "10.1016/j.jaci.2016.01.001",
language = "English (US)",
volume = "137",
pages = "973--982",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Food allergen immunotherapy

T2 - Current status and prospects for the future

AU - Wood, Robert A

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Food allergy is a common condition for which the only currently approved treatments are avoidance of the allergenic food and administration of emergency medications on accidental exposure. Over the past 10 years, significant advances have been made in the field of food immunotherapy, including oral immunotherapy, sublingual immunotherapy, and, more recently, epicutaneous immunotherapy. Each of these approaches are intended to induce some level of desensitization with chronic or repeated exposure to the allergenic food protein, although the risks and potential benefits of each treatment differ significantly. Although new data are emerging at a rapid pace and progress has been substantial, a number of important issues need to be addressed before introduction of these therapies into clinical practice. Furthermore, it is entirely possible that advances in this field will render these current approaches obsolete over the next 20 to 30 years as new and better therapies are developed.

AB - Food allergy is a common condition for which the only currently approved treatments are avoidance of the allergenic food and administration of emergency medications on accidental exposure. Over the past 10 years, significant advances have been made in the field of food immunotherapy, including oral immunotherapy, sublingual immunotherapy, and, more recently, epicutaneous immunotherapy. Each of these approaches are intended to induce some level of desensitization with chronic or repeated exposure to the allergenic food protein, although the risks and potential benefits of each treatment differ significantly. Although new data are emerging at a rapid pace and progress has been substantial, a number of important issues need to be addressed before introduction of these therapies into clinical practice. Furthermore, it is entirely possible that advances in this field will render these current approaches obsolete over the next 20 to 30 years as new and better therapies are developed.

KW - egg allergy

KW - epicutaneous immunotherapy

KW - Food allergy

KW - immunotherapy

KW - milk allergy

KW - omalizumab

KW - oral immunotherapy

KW - peanut allergy

KW - sublingual immunotherapy

UR - http://www.scopus.com/inward/record.url?scp=84963966468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84963966468&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2016.01.001

DO - 10.1016/j.jaci.2016.01.001

M3 - Article

VL - 137

SP - 973

EP - 982

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 4

ER -